Back
Akero Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
73
AKRO
Akero Therapeutics
Last Price:
35.32
Seasonality Move:
25.06%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Akero Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.18 | Buy |
| 20-day SMA: | 30.25 | Buy |
| 50-day SMA: | 28.46 | Buy |
| 200-day SMA: | 24.66 | Buy |
| 8-day EMA: | 31.43 | Buy |
| 20-day EMA: | 30.36 | Buy |
| 50-day EMA: | 28.77 | Buy |
| 200-day EMA: | 26.67 | Buy |
Akero Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 65.11 | Buy |
| Chaikin Money Flow: | 468165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.32 - 31.32) | Buy |
| Bollinger Bands (100): | (24.13 - 29.27) | Buy |
Akero Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 32.74 while AKRO 8-day simple moving average is 31.18, which is a Buy signal.
- The stock price of AKRO is 32.74 while Akero Therapeutics 20-day SMA is 30.25, which makes it a Buy.
- Akero Therapeutics 50-day simple moving average is 28.46 while AKRO share price is 32.74, making it a Buy technically.
- AKRO stock price is 32.74 and Akero Therapeutics 200-day simple moving average is 24.66, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
73
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a Buy
The current Akero Therapeutics [AKRO] share price is $32.74. The Score for AKRO is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
2.27B
Price in USD:
32.74
Share Volume:
473.98K
Akero Therapeutics 52-Week Range
52-Week High:
37.00
52-Week Low:
13.39
Buy
73
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?
The Akero Therapeutics stock price is 32.74 USD today. -
Will AKRO stock go up or go down?
Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Akero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
- Akero Therapeutics share price is 32.74 while AKRO 8-day exponential moving average is 31.43, which is a Buy signal.
- The stock price of AKRO is 32.74 while Akero Therapeutics 20-day EMA is 30.36, which makes it a Buy.
- Akero Therapeutics 50-day exponential moving average is 28.77 while AKRO share price is 32.74, making it a Buy technically.
- AKRO stock price is 32.74 and Akero Therapeutics 200-day simple moving average is 26.67, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.52 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
- AKRO Moving Average Covergence Divergence (MACD) indicator is 1.02, suggesting Akero Therapeutics is a Buy
- Akero Therapeutics Relative Strength Index (RSI) is 65.11, which suggest Akero Therapeutics is overbought
- The Bollinger Bands (25) for Akero Therapeutics is (28.32 - 31.32), which suggest Akero Therapeutics is a Buy
- The Bollinger Bands (100) for Akero Therapeutics is (24.13 - 29.27), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.